Clinical Application of Detection of the Fusion Gene in Acute Promyelocytic Leukemia with Reverse-Transcriptase Real-Time Quantitative PCR

ZHAO Jun-feng,ZHU Ping,ZHANG Ying,DU Jin-wei,LIU Hong-xing,LIU Jing,ZHUANG Xin,QIU Zhi-xiang

DOI: https://doi.org/10.3760/j:issn:1009-9158.2006.05.012

2006-01-01

Abstract:Objective To compare different reverse-transcriptase real-time quantitative PCR (RQ-PCR) methods with two fluorescent dyes in the detection of the PML-RARα fusion gene in acute promyelocytic leukemia (APL). Methods The RQ-PCR method based on SYBR GreenⅠ and Eva Green respectively was established to detect the PML-RARα fusion gene expression.The expression of PML-RARα in 56 patients with APL was determined and the sensitivity of RQ-PCR was compared with that of the conventional nested RT-PCR. Ten patients newly diagnosed APL were randomizedly divided into two groups, one group receiving all-trans retinoic acid (ATRA) plus chemical therapy and another receiving ATRA plus As_2O_3.The transcript level of PML-RARα in patients was determined every three weeks after treatment.Results The RQ-PCR with both SYBR GreenⅠ and Eva Green could detect as low as 50 copies of PML-RARα. The sensitivity of RQ-PCR was a little bit lower than that of the conventional nested RT-PCR.However, RQ-PCR had accurate quantification of fusion gene transcripts and was less liable to the contamination. The PML-RARα plasmids of high (10~7 copies) and low (10~3 copies) level and a cDNA sample of a patient were tested 8 times in one PML-RARα PCR assay to calculate the intra-assay variability (CV). The CVs were 7.31%, 8.26% and 5.02%, respectively. The median of the PML-RARα fusion gene expression level in the patients with APL before treatment was 0.070 (range:0.018-0.799). The fluorescent intensity of Eva Green was four times higher than that of SYBR GreenⅠ.The transcript of PML-RARα fusion gene decreased rapidly in both treatment groups in two to four weeks after treatment. No expression of the fusion gene could be detected in 80% patients of both groups after two months. There was no significant difference between the two groups.Conclusion RQ-PCR can quantify the expression of fusion gene in minimal residual disease (MRD) accurately. Both Eva Green and SYBR GreenⅠ can be used in RQ-PCR with Eva Green being more sensitive and effective. The fusion gene expression level can be used for monitoring the therapeutic effect with different treatment strategies effectively.